[go: up one dir, main page]

IL91572A0 - Pharmaceutical compositions for treating conditions appearing after damage comprising ace inhibitors - Google Patents

Pharmaceutical compositions for treating conditions appearing after damage comprising ace inhibitors

Info

Publication number
IL91572A0
IL91572A0 IL91572A IL9157289A IL91572A0 IL 91572 A0 IL91572 A0 IL 91572A0 IL 91572 A IL91572 A IL 91572A IL 9157289 A IL9157289 A IL 9157289A IL 91572 A0 IL91572 A0 IL 91572A0
Authority
IL
Israel
Prior art keywords
ace inhibitors
damage
pharmaceutical compositions
treating conditions
vessel
Prior art date
Application number
IL91572A
Other versions
IL91572A (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL91572A0 publication Critical patent/IL91572A0/en
Publication of IL91572A publication Critical patent/IL91572A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

ACE inhibitors are able to suppress the formation of neointima and the reduction of the vessel volume owing to vessel wall thickening after a vessel injury. They are accordingly suitable for the treatment and prevention of neointima formation after vessel injury, in particular for the prevention of arterial restenosis after angioplasty or of vessel wall thickening after vascular surgery in arteries and veins.
IL9157289A 1988-09-14 1989-09-08 Pharmaceutical compositions for treating conditions appearing after vascular damage comprising ace inhibitors IL91572A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH342188 1988-09-14

Publications (2)

Publication Number Publication Date
IL91572A0 true IL91572A0 (en) 1990-04-29
IL91572A IL91572A (en) 1994-01-25

Family

ID=4255625

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9157289A IL91572A (en) 1988-09-14 1989-09-08 Pharmaceutical compositions for treating conditions appearing after vascular damage comprising ace inhibitors

Country Status (13)

Country Link
EP (1) EP0363671B1 (en)
JP (1) JPH02121922A (en)
KR (1) KR900004337A (en)
AT (1) ATE100716T1 (en)
AU (1) AU625693B2 (en)
DE (1) DE58906814D1 (en)
DK (1) DK452089A (en)
ES (1) ES2061853T3 (en)
HU (1) HU206186B (en)
IE (1) IE892931L (en)
IL (1) IL91572A (en)
PT (1) PT91705B (en)
ZA (1) ZA896851B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3925759A1 (en) * 1989-08-03 1991-02-07 Thera Patent Verwaltungs Gmbh USE OF ACE INHIBITORS FOR ATHEROSKLEROSEPROPHYLAXE
DE3926606A1 (en) * 1989-08-11 1991-02-14 Hoechst Ag METHOD FOR THE TREATMENT OF CARDIALS AND VASCULAR HYPERTROPHY AND HYPERPLASIA
US5061694A (en) * 1989-10-23 1991-10-29 E. R. Squibb & Sons, Inc. Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor
US5212165A (en) * 1989-10-23 1993-05-18 E. R. Squibb & Sons, Inc. Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor
US5140012A (en) * 1990-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing pravastatin
CA2042159A1 (en) * 1990-05-31 1991-12-01 Miguel A. Ondetti Method for preventing onset of restenosis after angioplasty employing an ace inhibitor
CA2052014A1 (en) * 1990-10-19 1992-04-20 Henry Y. Pan Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor
EP0682947B1 (en) 1994-05-19 1997-09-10 Mitsubishi Chemical Corporation Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia
AU713530B2 (en) * 1995-03-24 1999-12-02 Molecumetics, Ltd. Beta-sheet mimetics and use thereof as protease inhibitors
AU708167B2 (en) * 1996-01-17 1999-07-29 Taiho Pharmaceutical Co., Ltd. Intimal hypertrophy inhibitors
EP1611886A3 (en) * 1999-08-30 2008-06-04 Sanofi-Aventis Deutschland GmbH Inhibitors of the renin-angiotensin system for the prevention of cardiovascular disorders
JP4904859B2 (en) * 2006-03-13 2012-03-28 大日本印刷株式会社 Printing unit and doctor blade polishing method
BRPI0621867A2 (en) * 2006-07-10 2011-12-20 Teva Pharma stable formulation consisting of a combination of a moisture sensitive drug and a second drug, and a process for its manufacture

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105776A (en) 1976-06-21 1978-08-08 E. R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4316906A (en) 1978-08-11 1982-02-23 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of substituted prolines
AT377496B (en) 1981-06-19 1985-03-25 Voith Gmbh J M DEVICE FOR WINDING A TRACK OF GOODS ON A NEWLY INSERTED WRAPPING SLEEVE IN A DOUBLE-CARRIER ROLLING MACHINE

Also Published As

Publication number Publication date
PT91705B (en) 1995-05-31
DE58906814D1 (en) 1994-03-10
HUT51148A (en) 1990-04-28
ATE100716T1 (en) 1994-02-15
EP0363671B1 (en) 1994-01-26
ZA896851B (en) 1990-06-27
JPH02121922A (en) 1990-05-09
EP0363671A2 (en) 1990-04-18
HU206186B (en) 1992-09-28
AU4124089A (en) 1990-03-22
DK452089D0 (en) 1989-09-13
IE892931L (en) 1990-03-14
PT91705A (en) 1990-03-30
ES2061853T3 (en) 1994-12-16
AU625693B2 (en) 1992-07-16
IL91572A (en) 1994-01-25
EP0363671A3 (en) 1991-12-11
KR900004337A (en) 1990-04-12
DK452089A (en) 1990-03-15

Similar Documents

Publication Publication Date Title
IL91572A0 (en) Pharmaceutical compositions for treating conditions appearing after damage comprising ace inhibitors
EP1649853A3 (en) Microtubule stabilizing agents for treating atherosclerosis or restenosis
DE69731652D1 (en) METHOD FOR TREATING ENDOTHELIAL INJURIES
ATE406909T1 (en) PREVENTION AND TREATMENT OF PATHOLOGIES ASSOCIATED WITH ABNORMAL PROLIFERATION OF SMOOTH MUSCLE CELLS
ATE302599T1 (en) PREPARATIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF DISEASES OF THE BODY PASSAGES
NO992769D0 (en) Procedure for the treatment and prevention of heart failure and ventricular dilation
HUT57063A (en) Process for producing pharmaceutical composition for treating vaso-construction
HU911620D0 (en) Process for the production of a medical prepartion of treating arteriosclerosis, containing the combination of ace inhibitor and active agent decreasing cholesterol level
JPS562962A (en) Glycolic acid oxidase inhibitor 44substitutedd33hydroxyy33pyrolinee2*55done
CA2162587A1 (en) Therapeutic inhibitor of vascular smooth muscle cells
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
CA2340320A1 (en) Use of an angiogenic factor for the treatment of microascular angiopathies
ATE216888T1 (en) DESFERRI-EXOCHELINE FOR THE TREATMENT OF ATHEROSCLERosis AND VASCULAR DAMAGE BY PREVENTING SMOOTH MUSCLE CELL PROLIFERATION
WO1995015161A3 (en) Medicament for treating heart insufficiency
NO924637D0 (en) PROCEDURE FOR PREVENTING REPEATING OF ARTERIES
GB9004348D0 (en) New use of catechol derivatives and their physiologically acceptable salts and esters
UA37249C2 (en) Method for inhibiting stenosis and/or restenosis (variants), method for inhibiting restenosis upon surgery of coronary artery (variants), method for decreasing risk of non-acute ischemic complication upon reconstructive vascular surgery
BG100367A (en) The use of esters of n-alkylated, 1,4-dihydropyrimidinedicarboxylic acids as medicamentous forms
GB9016609D0 (en) Compositions for the active or prophylactic treatment of intravascular coagulation or thrombosis
CS846287A1 (en) Aid for vascular prostheses treatment of venous origin
IT228470Y1 (en) CATHETER FOR THE DESTRUCTION OF THE ARTERIES
BG101472A (en) Vascular transplant and method for its preparation

Legal Events

Date Code Title Description
RH Patent void